Nicole Murphy

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Wendell Taylor, attorney in fact for Nicole Murphy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicole Murphy:

Form 4 holding Head of Pharm Ops and Tech

BIOGEN INC.

Security class
Common Stock
Shares / value
19,611
Estimated value
$3,824,839
Report date
12 Feb 2026
Price
$195.04
Ownership
Direct
Form 4 holding Head of Pharm Ops and Tech

BIOGEN INC.

Security class
Restricted Stock Unit
Shares / value
10,560
Estimated value
$0
Report date
13 Feb 2026
Price
$142.54
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Nicole Murphy

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .